Clinical Trials Logo

Whooping Cough clinical trials

View clinical trials related to Whooping Cough.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04793620 Terminated - Pertussis Clinical Trials

Pertussis Acellular Vaccine Adjuvanted With TQL1055

Start date: April 6, 2021
Phase: Phase 1
Study type: Interventional

This is a phase 1 study to evaluate the safety and immunogenicity of the semisynthetic saponin adjuvant TQL1055 administered in combination with an acellular pertussis vaccine.

NCT ID: NCT03188458 Terminated - Clinical trials for Diphtheria-Tetanus-Acellular Pertussis

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

Start date: May 29, 2018
Phase: Phase 4
Study type: Interventional

The purpose of the study is to support the recommendation of vaccination of all pregnant women in Colombia with Diptheria, tetanus and pertussis (dTpa) by studying the transfer of pertussis specific IgG antibodies from mother to the child.